["{\n\"step_by_step_thinking\": \"The question is about controlling PPH (Postpartum Hemorrhage) in a patient with heart disease. The relevant documents are related to cardiac failure, pharmacotherapy, and drug treatment. There's no direct mention of PPH or methylergometrine, oxytocin, misoprostol, or carboprost. However, the documents do discuss various medications and their effects on cardiac function. Inotropic drugs are mentioned as being used in heart failure treatment, but their potential adverse reactions are also discussed. This suggests that it's important to consider the patient's underlying cardiovascular condition when choosing a medication.\",\n\"answer_choice\": \"B\"\n}"]